Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles

Lipoprotein(a) is a Prevalent yet Vastly Underrecognized Risk Factor for Cardiovascular Disease

Challenges For The Future Of Complementary And Integrative Care

View More »

Google Scholar citation report
Citations : 924

Health Care : Current Reviews received 924 citations as per Google Scholar report

Flyer image
Health Care : Current Reviews peer review process verified at publons
Flyer image
Indexed In
  • Open J Gate
  • Academic Keys
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Google Scholar
View More
Useful Links
Share This Page
Journal Flyer
Flyer image
Open Access Journals
View More
LEADING CAUSES OF METHOTREXATE AND ANTIMALARIAL DRUGS DISCONTINUATION IN IRANIAN PATIENTS WITH RHEUMATOID ARTHRITIS
8th World Congress on Healthcare & Medical Tourism
November 17-18, 2016 | Dubai UAE

Bita Anvari

Kermanshah University of Medical Science, Iran

Scientific Tracks Abstracts: Health Care: Current Reviews

Abstract:

Abstract Background: Methotrexate (MTX) and anti-malarial drugs are widely prescribed for rheumatoid arthritis (RA) as diseasemodifying anti-rheumatic drugs (DMARDs). Some patients discontinue treatment because of their adverse effects which could induce disease reactivation. Aim of the work: We aimed to evaluate common causes of DMARD discontinuation such as MTX, chloroquine (CQ) and hydroxychloroquine (HCQ) in patients with rheumatoid arthritis. Patients and methods: We reviewed the records of RA patients referred to the rheumatologic clinic of Shariati Hospital in 2006 and their records were retrospectively reviewed till 1991. Patients who received MTX (with or without CQ or HCQ consumption) for at least one month were included to determine the frequency and more prevalent causes of drug discontinuation. Results: Among 295 RA patients, 28.5% discontinued MTX. Adverse drug effects were found in 27.4% of the patients. However, no serious adverse events such as cirrhosis were reported. Among 271 patients who received antimalarial agents, 41.3% discontinued treatment. 51.3% of drug withdrawals were because of ophthalmological consultation and presence of retinopathy, macular pigmentation, and keratopathy, without any persistent or serious ocular complication such as blindness. Only patients who discontinued treatment due to retinopathy were significantly older than the others. Conclusion: With respect to the relatively low rate of discontinuation due to adverse effects, MTX seems to be a safe drug for longterm use in RA patients. Serial eye examination for those using antimalarial drug will protect them against ocular toxicity which could further lead to higher rates of drug discontinuation.

Biography :

Bita Anvari is working at Internal Medicine Department, Imam Khomeini Hospital, Kermanshah University of Medical Science,

Email: Iran. banvari88@yahoo.com

PDF HTML